Spinal stimulation to help children with long-term spinal cord injury take steps
Tests stimulation through the skin to enable stepping in children with spinal cord injury.
Key facts
- Who runs it
- University of Louisville
- Where
- Louisville, United StatesSee the site
- Trial code
- Registry title
- Neuromodulation of Spinal Locomotor Circuitry to Elicit Stepping After Pediatric Spinal Cord Injury
- Status
- Enrolling by invitation
- People taking part
- 8 people, planned
- Started
- 12 Apr 2021
- Expected to end
- Nov 2026
- Type of study
- Interventional
- Treatments tested
- Biostim-5 transcutaneous spinal stimulator
- Transcutaneous Spinal Stimulator + Activity Based Locomotor Training
- Record updated
- 11 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children aged 4-12 years with a long-standing spinal cord injury who cannot stand or walk. It tests skin-surface spinal stimulation to help with stepping.
- Age
- 4 Years to 12 Years
- Sex
- All
- Disease stage
- Spinal cord injury acquired after birth, at T10 or higher, from injury or other causes. The injury happened more than one year ago. The child cannot stand, walk, or start steps.
- Earlier treatment
- The child must have left inpatient rehabilitation. Cannot join after Botox in the past 3 months, with current baclofen by mouth or a baclofen pump in use, or after scoliosis surgery since the injury.
Main reasons for not taking part
- Spinal cord injury present from birth
- Full dependence on a breathing machine
- Bone or muscle problems limiting movement, an unhealed fracture, or other medical problems limiting taking part
- Botox within past 3 months, or current baclofen use by mouth or pump
- For Aim 3: unwilling or unable to stop baclofen during training, or using trunk or leg braces
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Children with acquired, upper motor neuron (T10 and above) SCI, traumatic and non-traumatic,
- Chronic injury, defined as greater than one year post injury
- Age 4-12 years,
- Discharged from inpatient rehabilitation,
- Unable to stand, walk, or initiate steps
Who cannot take part
- Prior surgery for scoliosis, post SCI
- Musculoskeletal impairment limiting range of motion, unhealed fracture or other medical complication limiting participation,
- Botox use within past 3 months
- Current oral baclofen use,
- Baclofen pump in use,
- Congenital SCI,
- Total ventilator dependence; For Aim 3, additional exclusionary criteria are:
- Unwilling or unable to wean from baclofen during training,
- Use of braces (trunk or lower limb brace)
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 4 and 12 years old?
Where in United States
- Department of Neurosurgery, University of LouisvilleLouisville, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
Spinal cord injury (SCI) results in damage to the descending neural pathways and leads to the immediate dysfunction of multiple physiological systems below the level of injury. Like adults, children with SCI suffer from neuromuscular paralysis which results in the inability to sit, stand, and walk. Current therapeutic interventions largely aim to compensate for paralysis to achieve mobility based on the assumption that damage to the central nervous system is permanent and irreversible, e.g. use of braces, standers, and wheelchairs. The objective of this proposal is to investigate the use of transcutaneous spinal stimulation (TcStim) to enable stepping in children with chronic SCI.
Read full original descriptionShow less
The investigators will recruit 8 participants, ages 4-12 years with chronic, acquired SCI, T10 and above and non-ambulatory. The aims of this proposal are to 1) investigate the mechanisms of locomotor-specific regulation in the spinal neural circuitry of children with acquired SCI using single vs. multi-site TcStim, 2) investigate the capacity of the lumbosacral spinal cord for integration of task-specific input (e.g. load, speed) during facilitated stepping with and without TcStim, and 3) investigate the training effects of TcStim on the ability to step. Outcomes will provide a necessary initial step in the translation of scientific findings for neuromodulation from adults with SCI to children.
The group in the trial
- Transcutaneous Spinal Stimulation- Acute and with Training.Treatment being tested
For Aim 1: Participants will receive transcutaneous stimulation (TcStim) in supine or side lying position at a single or multi site spinal levels to produce stepping/locomotor activity in lower limbs. For Aim 2: TcStim will be delivered while participants are stepping on a computerized treadmill with an overhead partial body weight support (BWS) system and while stepping overground. For Aim 3: Participants will first receive a combination of Activity-based locomotor training (AB-LT)+TcStim for 60 sessions.
Treatment: Biostim-5 transcutaneous spinal stimulator and Transcutaneous Spinal Stimulator + Activity Based Locomotor Training
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Neuromodulation of Spinal Locomotor Circuitry to Elicit Stepping After Pediatric Spinal Cord Injury
- Plain-language title
- Spinal stimulation to help children with long-term spinal cord injury take stepsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT04077346, who can take part
- Record updated
- 11 September 2026